通用技术重药控股与强生创新制药签署战略合作协议

人民财讯
Oct 31

  人民财讯10月31日电,10月31日,通用技术重药控股强生创新制药签署战略合作协议,根据协议,双方将充分发挥自身平台资源及专业技术优势,聚焦麻精药品渠道管理关键环节,协同推动麻精药品渠道管理向更高标准、更严规范、更优效能迈进,共同打造以患者需求为导向、兼顾药品可及性与安全性的麻精药品供应链体系。

(文章来源:人民财讯)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10